Drugmakers in the red, as CMS releases its drugs that are subject to medicare price negotiations. The names getting hit the hardest, and how its impacting the weight loss drug race. Plus Is Intel on the market? M&A rumors helping boost the stock, but who could be the buyer? What a deal could mean for the beaten down chipmaker, and the impact on the tech space. Fast Money Disclaimer

Bank stocks surging as the group kicks off earnings season on a positive note. How their financials are faring, and the setup for the rest of earnings. And It wasn’t just the banks in the green. Stocks surging across the board as core inflation slows in December. What the data means for the central bank’s next move, as we count down to another Fed rate decision. Fast Money Disclaimer